Back to HZNP Stock Lookup

Horizon Therapeutics (HZNP) –

Jul 23, 2021 05:01 PM Form 4 Horizon Therapeutics For: Jul 22 Filed by: GREY MICHAEL G
Jul 21, 2021 08:49 AM Cowen Pounds the Table on Horizon Therapeutics (HZNP), Says Add to Positions Before Earnings
Jul 16, 2021 08:30 AM Fortune Names Horizon Therapeutics One of the 2021 Best Workplaces for Millennials™
Jul 9, 2021 05:01 PM Form 4 Horizon Therapeutics For: Jul 08 Filed by: MOZE BARRY
Jul 8, 2021 08:00 AM Horizon Therapeutics plc to Release Second-Quarter 2021 Financial Results and Host Webcast on Aug. 4, 2021
Jul 2, 2021 05:03 PM Form 4 Horizon Therapeutics For: Jul 01 Filed by: SHERMAN JEFFREY W
Jul 2, 2021 05:02 PM Form 4 Horizon Therapeutics For: Jul 01 Filed by: Thompson Elizabeth H.Z.
Jul 2, 2021 05:02 PM Form 4 Horizon Therapeutics For: Jun 30 Filed by: Walbert Timothy P
Jul 1, 2021 11:43 AM NIRI Chicago Elects 2021-2022 Officers and Directors
Jun 30, 2021 08:00 AM Horizon Therapeutics plc to Host Virtual R&D Day on Sept. 29, 2021
Jun 29, 2021 08:02 AM Horizon Therapeutics (HZNP) Enrolls First Patient in Phase 2 Trial of HZN-7734 for the Treatment of Systemic Lupus Erythematosus
Jun 29, 2021 08:00 AM Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating HZN-7734 for the Treatment of Systemic Lupus Erythematosus
Jun 28, 2021 09:00 AM Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease
Jun 23, 2021 09:18 AM Horizon Therapeutics (HZNP) Survey Implies CAGR >20% - Piper Sandler
Jun 22, 2021 01:33 PM Form CT ORDER Horizon Therapeutics
Jun 21, 2021 08:13 AM Horizon Therapeutics' (HZNP) KOL Call Shows Tepezza Use Broadening Among Clinicians - Jefferies
Jun 21, 2021 07:32 AM Arrowhead Pharmaceuticals (ARWR), Horizon Therapeutics (HZNP) Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Jun 21, 2021 07:30 AM Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Jun 21, 2021 07:30 AM Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Jun 18, 2021 12:32 PM Horizon Therapeutics (HZNP) Announces Multiple Presentations on NMOSD at EAN
Jun 18, 2021 12:30 PM Horizon Therapeutics plc Announces Multiple Presentations on Neuromyelitis Optica Spectrum Disorder (NMOSD) at the 7th Congress of the European Academy of Neurology (EAN)
Jun 17, 2021 07:06 AM Horizon Therapeutics (HZNP) Announces Purchase of Manufacturing Facility to Support Growth of On-Market Rare Disease and Pipeline Biologics
Jun 17, 2021 07:00 AM Horizon Therapeutics plc Announces Purchase of Manufacturing Facility to Support Growth of On-Market Rare Disease and Pipeline Biologics
Jun 11, 2021 05:00 PM Form 4 Horizon Therapeutics For: Jun 10 Filed by: McHugh Miles W
Jun 9, 2021 09:44 AM Horizon Therapeutics (HZNP) Gains on Newsletter Pick
Jun 4, 2021 08:36 AM Horizon Therapeutics' (HZNP) Tepezza Sales Rebound in April, Commentary from the Jefferies Healthcare Conference
Jun 3, 2021 04:42 PM Form 4 Horizon Therapeutics For: Jun 01 Filed by: Walbert Timothy P
Jun 2, 2021 08:00 AM Horizon Therapeutics plc Presents New Data on Robust Pipeline at EULAR European Congress of Rheumatology
May 27, 2021 08:00 AM Horizon Therapeutics plc Initiates ADVANCE Trial Evaluating KRYSTEXXA® (pegloticase injection) with Methotrexate for People Who Previously Developed Anti-Drug Antibodies on KRYSTEXXA Monotherapy
May 24, 2021 08:00 AM Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
May 21, 2021 08:00 AM Horizon Therapeutics plc Highlights Expanding R&D Efforts with Data Presentations at the EULAR European Congress of Rheumatology
May 20, 2021 08:30 AM Horizon Therapeutics plc Named One of the 2021 Best Workplaces in Chicago™ by Great Place to Work®
May 14, 2021 06:12 PM Form 4 Horizon Therapeutics For: May 14 Filed by: Hoelscher Paul W.
May 13, 2021 11:30 AM Horizon Therapeutics plc Ranked #1 in Overall Corporate Reputation Among U.S. Patient Groups that Report Working with the Company
May 12, 2021 05:02 PM Form 4 Horizon Therapeutics For: May 11 Filed by: Kent Jeff
May 12, 2021 05:01 PM Form 4 Horizon Therapeutics For: May 10 Filed by: Daniel William F
May 10, 2021 05:00 PM Form 3 Horizon Therapeutics For: Apr 29 Filed by: Thompson Elizabeth H.Z.
May 6, 2021 04:30 PM Horizon Therapeutics plc to Present at the Bank of America Securities 2021 Health Care Conference
May 6, 2021 08:34 AM Horizon Therapeutics (HZNP) Announces New Analysis of UPLIZNA for Neuromyelitis Optica Spectrum Disorder Published in Neurology Neuroimmunology & Neuroinflammation
May 6, 2021 08:30 AM New Analysis of UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD) Published in Neurology Neuroimmunology & Neuroinflammation
May 6, 2021 08:00 AM Horizon Therapeutics plc Announces Elizabeth H.Z. Thompson as a Healthcare Businesswomen’s Association 2021 Luminary
May 5, 2021 11:30 AM Horizon Therapeutics (HZNP) Tepezza is Now Underway, Add Stock - Cowen
May 5, 2021 07:22 AM Form 10-Q Horizon Therapeutics For: Mar 31
May 5, 2021 07:12 AM Horizon Therapeutics (HZNP) Misses Q1 EPS by 13c, Offers FY Guidance
May 5, 2021 07:10 AM Form 8-K Horizon Therapeutics For: May 05
May 5, 2021 07:00 AM Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc
Apr 30, 2021 07:04 PM Form 4 Horizon Therapeutics For: Apr 30 Filed by: Walbert Timothy P
Apr 30, 2021 07:03 PM Form 4 Horizon Therapeutics For: Apr 29 Filed by: Mahony Susan
Apr 30, 2021 07:02 PM Form 4 Horizon Therapeutics For: Apr 29 Filed by: Watkins Thomas
Apr 30, 2021 07:02 PM Form 4 Horizon Therapeutics For: Apr 29 Filed by: Witz Pascale

Back to HZNP Stock Lookup